Study to evaluate the effects of Reslizumab on Nasal Polyp Inflammation in patients with Aspirin Exacerbated Respiratory Disease
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Reslizumab (Primary)
- Indications Aspirin-induced asthma
- Focus Therapeutic Use
- 26 Mar 2018 New trial record
- 05 Mar 2018 Results presented at the 2018 Annual Meeting of the American Academy of Allergy, Asthma and Immunology